ALKBH5 and nonpapillary renal cell carcinoma: In ccRCC, transcriptomic data revealed a significant downregulation of FTO (log2FC = −5.2, q < 0.001) and ALKBH5 (log2FC = −4.7, q < 0.001) compared to controls.